Cephalon: FTC's Shot At Reverse Payments
The Federal Trade Commission has taken the next step in its long battle against "reverse payment settlements" that some argue delay entry by generic pharmaceutical manufacturers....To view the full article, register now.
Already a subscriber? Click here to view full article